- Home
- ARVN vs JFIN Comparison
ARVN vs JFIN Comparison
Compare ARVN & JFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- JFIN
- Stock Information
- Founded
- ARVN 2015
- JFIN 2011
- Country
- ARVN United States
- JFIN China
- Employees
- ARVN 430
- JFIN N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- JFIN Finance: Consumer Services
- Sector
- ARVN Health Care
- JFIN Finance
- Exchange
- ARVN Nasdaq
- JFIN Nasdaq
- Market Cap
- ARVN 676.2M
- JFIN 547.0M
- IPO Year
- ARVN 2018
- JFIN 2019
- Fundamental
- Price
- ARVN $9.45
- JFIN $10.26
- Analyst Decision
- ARVN Buy
- JFIN
- Analyst Count
- ARVN 23
- JFIN 0
- Target Price
- ARVN $17.61
- JFIN N/A
- AVG Volume (30 Days)
- ARVN 2.6M
- JFIN 63.0K
- Earning Date
- ARVN 11-04-2025
- JFIN 11-19-2025
- Dividend Yield
- ARVN N/A
- JFIN 7.94%
- EPS Growth
- ARVN N/A
- JFIN 33.85
- EPS
- ARVN N/A
- JFIN 4.21
- Revenue
- ARVN $372,800,000.00
- JFIN $908,895,698.00
- Revenue This Year
- ARVN $1.01
- JFIN N/A
- Revenue Next Year
- ARVN N/A
- JFIN N/A
- P/E Ratio
- ARVN N/A
- JFIN $2.39
- Revenue Growth
- ARVN 299.57
- JFIN 8.19
- 52 Week Low
- ARVN $5.90
- JFIN $5.18
- 52 Week High
- ARVN $29.61
- JFIN $19.23
- Technical
- Relative Strength Index (RSI)
- ARVN 57.54
- JFIN 43.01
- Support Level
- ARVN $9.01
- JFIN $9.62
- Resistance Level
- ARVN $9.55
- JFIN $10.27
- Average True Range (ATR)
- ARVN 0.49
- JFIN 0.45
- MACD
- ARVN -0.10
- JFIN 0.07
- Stochastic Oscillator
- ARVN 44.37
- JFIN 42.32
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About JFIN Jiayin Group Inc.
Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.